Intec Pharma Ltd.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$400K

34 transactions

Summary

Intec Pharma Ltd. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $117KSales: $283K14 insiders

Date	Insider	Type	Value
2020-01-31	Joint reporting: Oren Dan; Dexcel Pharma Technologies Ltd.	Sell	$225K
2020-02-04	Joint reporting: Oren Dan; Dexcel Pharma Technologies Ltd.	Sell	$32K
2020-02-03	Joint reporting: Oren Dan; Dexcel Pharma Technologies Ltd.	Sell	$26K
2019-08-28	Meckler Jeffrey A(Chief Executive Officer)	Buy	$14K
2019-11-19	Silberman Issac	Sell	$500
2020-09-16	Navon Nadav(Chief Operating Officer)	A	$0
2020-09-16	Linscott Walt Addison(Chief Business Officer)	A	$0
2020-09-16	Sassi Nir(Chief Financial Officer)	A	$0
2020-07-15	KOZARICH JOHN W	A	$0
2020-07-15	Hayes William B	A	$0
2020-07-15	Karah Hila	A	$0
2020-07-15	MADDALUNA ANTHONY J	A	$0
2020-07-15	Meckler Jeffrey A(Chief Executive Officer)	A	$0
2020-07-15	Pomerantz Roger	A	$0
2020-02-17	GENDREAU R MICHAEL(Chief Medical Officer)	A	$0
2020-02-17	Linscott Walt Addison(Chief Business Officer)	A	$0
2020-02-17	Navon Nadav(Chief Operating Officer)	A	$0
2020-02-17	Sassi Nir(Chief Financial Officer)	A	$0
2019-09-13	Linscott Walt Addison(Chief Business Officer)	A	$0
2019-09-13	Sassi Nir(Chief Financial Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Intec Pharma Ltd. — Contributions, Lobbying & Contracts | Poliscope